Sweetened beverage consumption and risk of liver cancer by diabetes status: A pooled analysis

Cancer Epidemiol. 2022 Aug:79:102201. doi: 10.1016/j.canep.2022.102201. Epub 2022 Jun 18.

Abstract

Background: Consumption of sweetened beverages has been linked to several risk factors for liver cancer including diabetes. Studies investigating the role of sweetened beverage consumption and liver cancer, however, are limited. As persons with diabetes are advised against consumption of sugar, the objective of this study was to examine the role of sweetened beverage consumption and liver cancer risk by diabetes status.

Methods: Data from two U.S. cohorts: the NIH-AARP Diet and Health Study, and the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial were harmonized and pooled. Hazard ratios and 95%CI were estimated using Cox proportional hazard models stratified by median follow-up time.

Results: Among persons without diabetes, there were no statistical evidence of associations between liver cancer and consumption of sweetened beverages overall, sugar sweetened beverages (SSB), or artificially sweetened beverages (ASB). Sugar sweetened (SS) soda consumption, however, was associated with liver cancer in the first follow-up interval (HR:1.18. 95%CI: 1.03, 1.35). In contrast, among persons with diabetes, there were significant associations between liver cancer and consumption of sweetened beverages overall (HR: 1.12, 95%CI 1.01, 1.24), ASBs (HR: 1.13, 95% CI: 1.02, 1.25), soda overall (HR: 1.13, 95% CI: 1.00, 1.26) and artificially sweetened (AS) soda (HR: 1.13, 95% CI: 1.01, 1.27) in the first follow-up interval.

Conclusions: Increased soda consumption may be associated with risk of liver cancer. The results suggest that decreasing consumption of SS soda by persons without diabetes, and AS soda by persons with diabetes, could be associated with reduced liver cancer risk.

Keywords: Diabetes; Liver cancer; Sweetened Beverages.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Beverages / adverse effects
  • Diabetes Mellitus* / epidemiology
  • Humans
  • Liver Neoplasms* / chemically induced
  • Liver Neoplasms* / epidemiology
  • Liver Neoplasms* / etiology
  • Male
  • Sugar-Sweetened Beverages* / adverse effects
  • Sugars
  • Sweetening Agents / adverse effects

Substances

  • Sugars
  • Sweetening Agents